Dividat utilizes a standardized evidence-based methodology for all research and product development

Dr. Eleftheria Giannouli explaining the Dividat Senso

Publications on Dividat Senso

2021

A. Sch├Ąttin, et al.

[PDF] Design and Evaluation of User-Centered Exergames for Patients With Multiple Sclerosis: Multilevel Usability and Feasibility Studies

2021

Swinnen et. al.

[PDF] The efficacy of exergaming in people with major neurocognitive disorder residing in long-term care facilities

2020

J. Bakker, et al.

[PDF] Balance training monitoring and individual response during unstable vs. T stable balance Exergaming in elderly adults: Findings from a randomized controlled trial

2020

Swanenburg et al.

[PDF] Exergaming with integrated head turn task improves compensatory saccade pattern in some patients with chronic peripheral unilateral vestibular hypofunction

2019

de Bruin

[PDF] Playing Exergames Facilitates Central Drive to the Ankle Dorsiflexors During Gait in Older Adults; a Quasi-Experimental Investigation

2014

van het Reve, D. de Bruin.

[PDF] Strength-balance supplemented with computerized cognitive training to improve dual task gait and divided attention in older adults: a multicenter randomized-controlled trial

Research at the ETH in Zurich layed the ground work for the Dividat Senso. The Dividat Senso is a research-backed product and sparked a lot of interest, not only with clinicians, but also in the research community.

Dividat is partnering with the most recognized research institutions in the world.

Research institutions throughout the world continue to show interest with Dividat in a broad variety of fields - cognitive health, fall reduction, adolescence and corporate health

World leading research institute

ETH Zurich regularly features in international rankings as one of the best universities in the world and the leading university in continental Europe. ETH Zurich stands on a bedrock of true Swiss values.

Dividat is an award-winning company